Basics Arcus Biosciences, Inc. IPO Date: March 12, 2018 Sector: Healthcare Industry: Biotech Market Cap: $1.3B Activated in VL: True Average Daily Range Avg Daily Range: $0.59 | 3.01% Avg Daily Range (30 D): $0.26 | 2.58% Avg Daily Range (90 D): $0.27 | 2.86% Institutional Daily Volume Avg Daily Volume: .51M Avg Daily Volume (30 D): .63M Avg Daily Volume (90 D): .77M Trade Size Avg Trade Size (Sh.): 78 Avg Trade Size (Sh.) (30 D): 68 Avg Trade Size (Sh.) (90 D): 78 Institutional Trades Total Inst.Trades: 2,534 Avg Inst. Trade: $2.33M Avg Inst. Trade (30 D): $1.18M Avg Inst. Trade (90 D): $1.58M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.8M Avg Closing Trade (30 D): $1.2M Avg Closing Trade (90 D): $1.44M Avg Closing Volume: 133.77K     News Dec 2, 2024 @ 3:18 PM Biotech Advances Drive Cancer Research as Global R... Source: Prnewswire Aug 23, 2024 @ 3:47 PM Retinoblastoma Treatment Market to Surpass $2 Bill... Source: Researchandmarkets.Com Jul 8, 2024 @ 9:00 PM Cracking The Code: Understanding Analyst Reviews F... Source: Benzinga Insights, Benzinga Staff Writer Jun 7, 2024 @ 2:55 PM Is The Options Market Predicting a Spike In Arcus ... Source: Zacks Equity Research Jun 3, 2024 @ 5:59 PM Gilead (GILD), RCUS Announce Data From Colorectal ... Source: Zacks Equity Research Financials   TTM Q2 2025 Q1 2025 Basic EPS $-3.12 $ $-1.14 Diluted EPS $-3.12 $ $-1.14 Revenue $ 262M $ 160M $ 28M Gross Profit $ $ $ Net Income / Loss $ -298M $ M $ -112M Operating Income / Loss $ -338M $ -8M $ -122M Cost of Revenue $ $ $ Net Cash Flow $ 92M $ 56M $ 42M PE Ratio